Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paola Fortugno is active.

Publication


Featured researches published by Paola Fortugno.


Current Opinion in Biotechnology | 1996

Selection of biologically active peptides by phage display of random peptide libraries.

Riccardo Cortese; Paolo Monaci; Alessandra Luzzago; Claudia Santini; Fabrizia Bartoli; Irene Cortese; Paola Fortugno; Giovanni Galfré; Alfredo Nicosia; Franco Felici

Random peptide libraries displayed on phage are used as a source of peptides for epitope mapping, for the identification of critical amino acids responsible for protein-protein interactions and as leads for the discovery of new therapeutics. Efficient and simple procedures have been devised to select peptides binding to purified proteins, to monoclonal and polyclonal antibodies and to cell surfaces in vivo and in vitro.


International Journal of Cancer | 2003

Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients

Olga Minenkova; Andrea Pucci; Emiliano Pavoni; Amedeo De Tomassi; Paola Fortugno; Nicola Gargano; Maurizio Cianfriglia; Stefano Barca; Sabino De Placido; Angelo Martignetti; Franco Felici; Riccardo Cortese; Paolo Monaci

Screening cDNA libraries from solid human tumors with sera of autologous patients (SEREX) has proven to be a powerful approach to identifying tumor antigens recognized by the humoral arm of the immune system. In many cases, application of this methodology has led to the discovery of novel tumor antigens as unknown gene products. We tried to improve the potency of the SEREX approach by combining it with phage‐display technology. We designed a new lambda vector to express protein fragments as N‐terminal fusions to the D capsid protein and generated high‐complexity cDNA libraries from human breast carcinoma cell lines and solid tumors. Screening these phage‐displayed libraries required limited amounts of sera from patients and efficiently identified several tumor antigens specifically reacting with sera from breast cancer patients.


Journal of Immunological Methods | 2000

Affinity maturation of ligands for HCV-specific serum antibodies.

Lorena Urbanelli; Paola Fortugno; Fabrizia Bartoli; Maurizio Nuzzo; Amedeo De Tomassi; Franco Felici; Paolo Monaci

We have previously screened a phage-displayed random peptide library using sera from patients and identified ligands binding to antibodies specifically associated with the hepatitis C virus infection. The ability of these peptides to detect HCV-specific antibodies was improved through an in vitro procedure which mimics the natural process of antibody affinity maturation operating in secondary immune response. Libraries were generated by mutating the sequence of the original peptide through a protocol that efficiently introduced substitution, insertion and deletion mutations on a single or population of clones. Screening these libraries isolated mutants that displayed increased specific reactivity with a broader range of sera from HCV-infected patients. Several variants of the original peptide were identified which discriminate between the various components of the specific polyclonal response. This methodology to select artificial ligands from RPL using sera and to enhance their diagnostic properties by affinity maturation makes the development of a diagnostic assay to detect disease-associated antibodies feasible, without requiring the natural antigen.


Parasite Immunology | 2002

Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica.

Helen Melzer; Paola Fortugno; Erfan Mansouri; Franco Felici; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd Ulrich Von Specht; Michael Duchêne

Entamoeba histolytica is the protozoan parasite responsible for intestinal amoebiasis and amoebic liver abscess, which cause significant morbidity and mortality in many countries of the world. Proteophosphoglycans (PPGs, also known as lipophosphoglycans, LPGs, or lipopeptidophosphoglycans, LPPGs) represent dominant surface components of E. histolytica. Passive immunization with a monoclonal antibody (EH5) directed against these components protected SCID mice from amoebic liver abscess, so PPGs might be regarded as vaccine candidates; however, their structure is very complex and only known in part. They are glycosylphosphatidylinositol‐linked polypeptides of unknown sequence carrying glycan side‐chains linked to serine residues via phosphodiester bonds. In order to identify peptide mimics of the E. histolytica PPG antigens, we screened six different phage‐displayed random peptide libraries with the antibody EH5. Various peptide mimics of different length were identified and, in all the peptides, a distinct consensus sequence Gly‐Thr‐His‐Pro‐X‐Leu could be identified. The phages strongly bound to the antibody, and the natural antigen inhibited binding of the phages to antibody EH5. In addition, several of the phages induced a significant immunoglobulin G response against amoebic antigens in immunized mice.


European Journal of Immunology | 1997

Induction of anti‐carbohydrate antibodies by phage library‐selected peptide mimics

Armelle Phalipon; Antonella Folgori; Josette Arondel; Giuseppe Sgaramella; Paola Fortugno; Riccardo Cortese; Philippe J. Sansonetti; Franco Felici


FEBS Journal | 2001

ADAM‐HCV, a new‐concept diagnostic assay for antibodies to hepatitis C virus in serum

Olga Minenkova; Nicola Gargano; Amedeo De Tomassi; Francesca Bellintani; Andrea Pucci; Paola Fortugno; Elena Fuscaldi; Antonello Pessi; Maria Rapicetta; Michela Miceli; Paola Iudicone; Riccardo Cortese; Franco Felici; Paolo Monaci


Analytical Biochemistry | 2000

Colony assay for phage-displayed libraries

Olga Minenkova; Amedeo De Tomassi; Francesca Bellintani; Paola Fortugno; Nicola Gargano; Franco Felici; Paolo Monaci


Research in Immunology | 1998

Peptide mimicry of carbohydrate structures

Armelle Phalipon; Antonella Folgori; Josette Arondel; G. Sgaramella; Paola Fortugno; Riccardo Cortese; Philippe J. Sansonetti; Franco Felici


EMBO Workshop on "Pathogenesis of amoebiasis: from genomics to disease" | 2003

Proteophosphoglycan antigens on the surface of Entamoeba histolytica: mimotopes and a recombinant antibody

Helen Melzer; M. Binder; P. Rendi-Wagner; Alexandra Marinets; Karin Baier; Paola Fortugno; Franco Felici; Erfan Mansouri; B. . U. Von Specht; Herwig Kollaritsch; Gerhard Wiedermann; Ursula Wiedermann; M. Duchne


Archives of Medical Research | 2000

Isolation of phage mimotopes mimicking a protective epitope of GPI-linked proteophosphoglycan antigens of Entamoeba histolytica.

Helen Melzer; Franco Felici; Erfan Mansouri; Paola Fortugno; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd-Ulrich von Specht; Michael Duchêne

Collaboration


Dive into the Paola Fortugno's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge